Background/Aims: Deposits of phosphorylated tau protein and convergence of pathology in the hippocampus are the hallmarks of neurodegenerative tauopathies. Thus we aimed to evaluate whether regional and cellular vulnerability patterns in the hippocampus distinguish tauopathies or are influenced by their concomitant presence. Methods: We created a heat map of phospho-tau (AT8) immunoreactivity patterns in 24 hippocampal subregions/layers in individuals with Alzheimer's disease (AD)-related neurofibrillary degeneration (n = 40), Pick's disease (n = 8), progressive supranuclear palsy (n = 7), corticobasal degeneration (n = 6), argyrophilic grain disease (AGD, n = 18), globular glial tauopathy (n = 5), and tau-astrogliopathy of the elderly (n = 10). AT8 immunoreactivity patterns were compared by mathematical analysis. Results: Our study reveals disease-specific hot spots and regional selective vulnerability for these disorders. The pattern of hippocampal AD-related tau pathology is strongly influenced by concomitant AGD. Mathematical analysis reveals that hippocampal involvement in primary tauopathies is distinguishable from early-stage AD-related neurofibrillary degeneration. Conclusion: Our data demonstrate disease-specific AT8 immunoreactivity patterns and hot spots in the hippocampus even in tauopathies, which primarily do not affect the hippocampus. These hot spots can be shifted to other regions by the co-occurrence of tauopathies like AGD. Our observations support the notion that globular glial tauopathies and tau-astrogliopathy of the elderly are distinct entities.

1.
Kovacs GG, Botond G, Budka H: Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol 2010;119:389-408.
2.
Lee VM, Goedert M, Trojanowski JQ: Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-1159.
3.
Jellinger KA, Attems J: Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol 2007;113:107-117.
4.
Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, Giaccone G, Hatanpaa KJ, Holton JL, Josephs KA, Powers J, Spina S, Takahashi H, White CL 3rd, Revesz T, Kovacs GG: Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol 2013;126:537-544.
5.
Kovacs GG, Molnar K, Laszlo L, Strobel T, Botond G, Honigschnabl S, Reiner-Concin A, Palkovits M, Fischer P, Budka H: A peculiar constellation of tau pathology defines a subset of dementia in the elderly. Acta Neuropathol 2011;122:205-222.
6.
Kovacs GG, Milenkovic I, Wohrer A, Hoftberger R, Gelpi E, Haberler C, Honigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H: Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 2013;126:365-384.
7.
Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA: Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989;8:393-399.
8.
Buee L, Delacourte A: Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999;9:681-693.
9.
de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, Halliday G, MacKenzie J, Ravid R, Dickson D, Wszolek Z, Iwatsubo T, Pickering-Brown SM, Holton J, Lees A, Revesz T, Mann DM: An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol 2006;111:329-340.
10.
Song YJ, Halliday GM, Holton JL, Lashley T, O'Sullivan SS, McCann H, Lees AJ, Ozawa T, Williams DR, Lockhart PJ, Revesz TR: Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J Neuropathol Exp Neurol 2009;68:1073-1083.
11.
Santpere G, Ferrer I: Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation. Brain Pathol 2009;19:177-187.
12.
Parent A: Carpenter's Human Anatomy. Baltimore, Williams & Wilkins, 1996, pp 760-773.
13.
O'Keefe J, Nadel L: The Hippocampus as a Cognitive Map. Oxford, Clarendon, 1978.
14.
Lavenex PB, Amaral DG, Lavenex P: Hippocampal lesion prevents spatial relational learning in adult macaque monkeys. J Neurosci 2006;26:4546-4558.
15.
Eichenbaum H, Dudchenko P, Wood E, Shapiro M, Tanila H: The hippocampus, memory, and place cells: is it spatial memory or a memory space? Neuron 1999;23:209-226.
16.
Morris RG, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-683.
17.
Nadel L: The hippocampus and space revisited. Hippocampus 1991;1:221-229.
18.
O'Keefe J, Dostrovsky J: The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Res 1971;34:171-175.
19.
Scoville WB, Milner B: Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 1957;20:11-21.
20.
Squire LR: Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992;99:195-231.
21.
Colgin LL, Moser EI, Moser MB: Understanding memory through hippocampal remapping. Trends Neurosci 2008;31:469-477.
22.
Moser EI: The multi-laned hippocampus. Nat Neurosci 2011;14:407-408.
23.
Kovacs GG, Majtenyi K, Spina S, Murrell JR, Gelpi E, Hoftberger R, Fraser G, Crowther RA, Goedert M, Budka H, Ghetti B: White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 2008;67:963-975.
24.
Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H: Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 2008;18:484-496.
25.
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K: Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404.
26.
Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S: Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 2004;63:911-918.
27.
Kovacs GG, Budka H: Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol 2010;29:271-288.
28.
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT: National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012;123:1-11.
29.
Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T: Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007;130:1566-1576.
30.
Braak E, Braak H, Mandelkow EM: A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-567.
31.
Insausti R: Hippocampal formation; in Mai J (ed): The Human Nervous System. San Diego, Elsevier, 2012, pp 896-942.
32.
Arnold SE, Toledo JB, Appleby DH, Xie SX, Wang LS, Baek Y, Wolk DA, Lee EB, Miller BL, Lee VM, Trojanowski JQ: A comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. J Comp Neurol 2013;521:4339-4355.
33.
Rabano A, Rodal I, Cuadros R, Calero M, Hernandez F, Avila J: Argyrophylic grain pathology as a natural model of tau propagation. J Alzheimers Dis 2014;40(Suppl 1):S123-S133.
34.
Parvizi J, Van Hoesen GW, Damasio A: The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 2001;49:53-66.
35.
Thal DR, Holzer M, Rub U, Waldmann G, Gunzel S, Zedlick D, Schober R: Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol 2000;163:98-110.
36.
Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG: Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 2014;73:81-97.
37.
Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena R: Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. J Alzheimers Dis 2007;12:365-375.
38.
Puig B, Rey MJ, Ferrer I: Individual and regional variations of phospho-tau species in progressive supranuclear palsy. Acta Neuropathol 2005;110:261-268.
39.
Guillozet-Bongaarts AL, Glajch KE, Libson EG, Cahill ME, Bigio E, Berry RW, Binder LI: Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol 2007;113:513-520.
40.
Gilbert PE, Kesner RP, Lee I: Dissociating hippocampal subregions: double dissociation between dentate gyrus and CA1. Hippocampus 2001;11:626-636.
41.
Kesner RP, Gilbert PE, Wallenstein GV: Testing neural network models of memory with behavioral experiments. Curr Opin Neurobiol 2000;10:260-265.
42.
Kesner RP, Hopkins RO: Mnemonic functions of the hippocampus: a comparison between animals and humans. Biol Psychol 2006;73:3-18.
43.
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL: Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
44.
Josephs KA, Whitwell JL, Parisi JE, Knopman DS, Boeve BF, Geda YE, Jack CR Jr, Petersen RC, Dickson DW: Argyrophilic grains: a distinct disease or an additive pathology? Neurobiol Aging 2008;29:566-573.
45.
Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I: Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
46.
Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128:1247-1258.
47.
Armstrong RA, Cairns NJ, Lantos PL: A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration. Exp Neurol 2000;163:348-356.
48.
Armstrong RA, Lantos PL, Cairns NJ: Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 2009;28:46-53.
49.
Togo T, Cookson N, Dickson DW: Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 2002;12:45-52.
50.
Jinno S, Kosaka T: Cellular architecture of the mouse hippocampus: a quantitative aspect of chemically defined GABAergic neurons with stereology. Neurosci Res 2006;56:229-245.
51.
Freund TF, Buzsaki G: Interneurons of the hippocampus. Hippocampus 1996;6:347-470.
52.
Klausberger T, Somogyi P: Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 2008;321:53-57.
53.
McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A: Targeted deletion in astrocyte intermediate filament (GFAP) alters neuronal physiology. Proc Natl Acad Sci USA 1996;93:6361-6366.
54.
Bezzi P, Vesce S, Panzarasa P, Volterra A: Astrocytes as active participants of glutamatergic function and regulators of its homeostasis. Adv Exp Med Biol 1999;468:69-80.
55.
Bezzi P, Domercq M, Vesce S, Volterra A: Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog Brain Res 2001;132:255-265.
56.
Agulhon C, Fiacco TA, McCarthy KD: Hippocampal short- and long-term plasticity are not modulated by astrocyte Ca2+ signaling. Science 2010;327:1250-1254.
57.
Yang Y, Ge W, Chen Y, Zhang Z, Shen W, Wu C, Poo M, Duan S: Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc Natl Acad Sci USA 2003;100:15194-15199.
58.
Perea G, Navarrete M, Araque A: Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009;32:421-431.
59.
Bezzi P, Volterra A: Astrocytes: powering memory. Cell 2011;144:644-645.
60.
Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, Alberini CM: Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 2011;144:810-823.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.